Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isa Mambetsariev

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|July 14, 2023
Clinical Network Systems Biology: Traversing the Cancer MultiverseIsa Mambetsariev, Jeremy Fricke, Stephen B Gruber, et al.
Oncotarget|May 8, 2018
Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patientsValeriy Poroyko, Tamara Mirzapoiazova, Arin Nam, et al.
Journal of Clinical Medicine|July 19, 2019
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial BiologyIsa Mambetsariev, Tamara Mirzapoiazova, Frances Lennon, et al.
JCO Precision Oncology|September 1, 2023
Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the BlockJason Liu, Arya Amini, Ameish Govindarajan, et al.
JCO Oncology Practice|July 9, 2020
Evaluation of Omics-Based Strategies for the Management of Advanced Lung CancerRavi Salgia, Isa Mambetsariev, Rebecca Pharaon, et al.
Chest|April 20, 2021
Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung CancerMoom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Translational Lung Cancer Research|March 21, 2025
Novel <i>LZTR1</i> germline mutation as a mechanism of resistance to osimertinib in <i>EGFR</i>-mutated lung adenocarcinoma: a case reportWai Park, Jeremy Fricke, Isa Mambetsariev, et al.
American Journal of Respiratory Cell and Molecular Biology|July 4, 2014
Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammationFanyong Meng, Isa Mambetsariev, Yufeng Tian, et al.
Med (New York, N.Y.)|August 9, 2025
Current paradigm of EGFR<sup>ins20</sup> in non-small cell lung cancer: A long way forwardBeatriz Viesser Miyamura, Isa Mambetsariev, Jeremy Fricke, et al.
JAMA Oncology|November 27, 2024
Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A ReviewJyoti Malhotra, Isa Mambetsariev, Gregory Gilmore, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|July 14, 2023
Clinical Network Systems Biology: Traversing the Cancer MultiverseIsa Mambetsariev, Jeremy Fricke, Stephen B Gruber, et al.
Oncotarget|May 8, 2018
Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patientsValeriy Poroyko, Tamara Mirzapoiazova, Arin Nam, et al.
Journal of Clinical Medicine|July 19, 2019
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial BiologyIsa Mambetsariev, Tamara Mirzapoiazova, Frances Lennon, et al.
JCO Precision Oncology|September 1, 2023
Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the BlockJason Liu, Arya Amini, Ameish Govindarajan, et al.
JCO Oncology Practice|July 9, 2020
Evaluation of Omics-Based Strategies for the Management of Advanced Lung CancerRavi Salgia, Isa Mambetsariev, Rebecca Pharaon, et al.
Chest|April 20, 2021
Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung CancerMoom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Translational Lung Cancer Research|March 21, 2025
Novel <i>LZTR1</i> germline mutation as a mechanism of resistance to osimertinib in <i>EGFR</i>-mutated lung adenocarcinoma: a case reportWai Park, Jeremy Fricke, Isa Mambetsariev, et al.
American Journal of Respiratory Cell and Molecular Biology|July 4, 2014
Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammationFanyong Meng, Isa Mambetsariev, Yufeng Tian, et al.
Med (New York, N.Y.)|August 9, 2025
Current paradigm of EGFR<sup>ins20</sup> in non-small cell lung cancer: A long way forwardBeatriz Viesser Miyamura, Isa Mambetsariev, Jeremy Fricke, et al.
JAMA Oncology|November 27, 2024
Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A ReviewJyoti Malhotra, Isa Mambetsariev, Gregory Gilmore, et al.
Pageof 8